Related Experiment Videos
Myelin basic protein, an autoantigen in multiple sclerosis, is selectively processed by human trypsin 4
Péter Medveczky1, József Antal, András Patthy
1Department of Biochemistry, Eötvös Loránd University, Pázmány Péter st. 1/C, H-1117 Budapest, Hungary.
FEBS Letters
|January 18, 2006
Summary
Human trypsin 4 specifically cleaves myelin basic protein, a key factor in neurodegenerative diseases. This protease may play a role in the development of multiple sclerosis.
Area of Science:
- Neuroscience
- Biochemistry
- Proteomics
Background:
- Demyelination, involving myelin basic protein degradation, is implicated in neurodegenerative diseases.
- Understanding proteases involved in myelin breakdown is crucial for disease research.
Purpose of the Study:
- To compare the proteolytic activity of calpain, human trypsin 1, and human trypsin 4 on myelin basic protein.
- To identify specific cleavage sites of human trypsin 4 on myelin basic protein.
- To investigate the potential role of human trypsin 4 in multiple sclerosis pathogenesis.
Main Methods:
- In vitro enzymatic assays using lipid-bound and free human myelin basic protein.
- N-terminal amino acid sequencing and mass spectrometry for fragment identification.
- Synthesis and hydrolysis studies of a myelin basic protein peptide fragment.
Main Results:
- Human trypsin 4 demonstrated the most specific cleavage of myelin basic protein.
- Selective cleavage occurred at Arg79-Thr80 and Arg97-Thr98 peptide bonds in lipid-bound myelin basic protein.
- A synthetic peptide containing the Arg97-Thr98 site confirmed trypsin 4's high susceptibility to this bond.
Conclusions:
- Human trypsin 4 is a specific protease for myelin basic protein.
- The identified cleavage sites and specificity suggest a potential role for human trypsin 4 in multiple sclerosis.
- Further research is warranted to elucidate the precise involvement of human trypsin 4 in demyelinating diseases.